Specifications
Species Reactivity
Human; Rat
Applications
Application Notes
ELISA, IB, Inhibition
ELISA: Binds immobilized human and rat FIX and human FIXa only in the presence of calcium
Immunoblotting: Western blot detects human FIX and light chain of human FIXa under reduced conditions in presence of calcium.
Inhibition: Prolongs plasma clot time in aPTT clotting assay.
Recommended working dilution: Approximately 1-5 μg/ml. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded
Target
Alternative Names
F9; coagulation factor IX; Christmas disease; Factor IX; FIX; hemophilia B; plasma thromboplastic component; F9 p22; FIX F9; factor 9; factor IX F9; serine protease; Christmas factor; plasma thromboplastin component; P19; PTC; HEMB; THPH8; MGC129641; MGC1
Product Background
Antigen Description
This gene encodes vitamin K-dependent coagulation factor IX that circulates in the blood as an inactive zymogen. This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds.
Pathway
Blood Clotting Cascade, organism-specific biosystem; Complement and Coagulation Cascades, organism-specific biosystem; Complement and coagulation cascades, organism-specific biosystem; Complement and coagulation cascades, conserved biosystem; Extrinsic Pathway, organism-specific biosystem; Formation of Fibrin Clot (Clotting Cascade), organism-specific biosystem; Gamma-carboxylation of protein precursors, organism-specific biosystem;
Citations
Publication ()
Have you cited CAB-3290MH in a publication?
Let us know and earn a reward for your research.